Competitive intelligence on small-molecule drugs and the 80,000 patents covering them
Preview the database
See plans and pricing
This chart shows the top selling drugs for 2012. The leading drugs, by sales, were
Nexium, Abilify, Crestor, Advair Diskus, Cymbalta, Humira, Enbrel, Remicade, Copaxone, and Neulasta.
Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639